The CDC is working with the FDA and state officials to address a tuberculosis outbreak connected to recalled human bone tissue products sold to hospitals, surgical centers and dental clinics.
Six things to know:
1. The tuberculosis cases are linked to Aziyo Biologics' viable bone matrix products, which were recalled earlier this month after two patients treated with a viable bone matrix product made from one donor lot contracted tuberculosis.
2. The products were sent to seven states between Feb. 27 and June 20. Seven units of alloOss, a dental implant, made from the same donor were sent to dental offices in four states, the CDC told Becker's.
3. The CDC said July 25 that all facilities and states involved have been contacted and all unused products were removed from inventory.
4. The CDC said providers should work with state health departments to contact patients who underwent surgery using ViBone or alloOss lot #TDS222820 for evaluation and treatment.
5. Patients who received these products should begin treatment for tuberculosis even if they do not have any symptoms.
6. The CDC also recommended hospitals and dental offices identify healthcare personnel who may have been exposed to Mycobacterium tuberculosis during patient surgery or patient care.